XYZ Market Revenue, Regional & Country Share, Key Factors, Trends & Analysis, To 2026
The Global Endocrine Testing market was valued at USD 8.03 billion in 2018 and is expected to reach USD 15.09 billion by year 2026, at a CAGR of 8.1%. Endocrine testing involves examining urine or blood samples to detect the concentration of endocrinal hormones such as thyroid, diabetes, Cushing syndrome, etc. Technological Advancements in terms of accuracy, affordability, cost-effectiveness, and introduction of easy-to-operate test kits have facilitated the penetration of home-based diagnostics. Key market players today are focusing on investing in launching innovative products, thereby increasing their market footprint in the endocrine testing market.
Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness, increasing government support & obesity are some of the key factors projected to surge the demand for Endocrine testing, thereby propelling the market growth. Furthermore, a high prevalence of hyperthyroidism, hypothyroidism, and rising geriatric population are some of the key factors responsible for fueling market growth.
Key participants include AB Sciex, Abbott Laboratories, Beckman Coulter, bioMerieux SA, BioRad Laboratories, Biomedical Technologies, Agilent Technologies, Quest Diagnostics, Diasorin, Hoffmann- La Roche Ltd., Thermo Fisher Scientific, Quest Diagnostics and Siemens Healthineers.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/endocrine-testing-market
Further key findings from the report suggest
Various market players are engaged in developing new products. For instance, Helmholtz Zentrum München allied with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes
Sensors Segment is expected to witness lucrative growth with a CAGR of 8.6% during the forecast period
As of 2018, Tandem Mass Spectrometry segment dominated the market with a market share of 33.9% and is expected to maintain its lead due to its increasing use in combination with liquid chromatography which aids in overcoming challenges associated with traditional techniques in Endocrine testing
The Insulin test segment is expected to register fastest growth with a CAGR of 8.8% during the forecast period
The thyroid Stimulating hormone (TSH) segment is prophesied to dominate the global Endocrine testing market with a share of 0%
In the End-use, hospital users accounted for largest market share and is expected to be seen leading in the upcoming years
The North American region dominated the global endocrine testing market in in terms of revenue generation with a share of 3%
The Asia Pacific region is projected to be the fastest growing regional market with a CAGR of 9.1%. The factors fostering the market growth are increasing investments in Research and development by key private companies and government to improve diagnostic and therapeutic areas in the region
Europe is the second largest region in terms of capturing the market share.
Request Free Sample: https://www.reportsanddata.com/sample-enquiry-form/2240
For the purpose of this report, Reports and Data has segmented the Endocrine Testing market on the basis of Test type, Technology type, End-use, and region:
Test Type (Revenue, USD Million; 2016–2026)
Estradiol
TSH
Insulin
Cortisol
FSH
hCG
LH
DHEAS
Progesterone
Testosterone
Prolactin
Others
Technology Type (Revenue, USD Million; 2016–2026)
Tandem Mass Spectrometry Immunoassay
Monoclonal & Polyclonal antibody technologies
Sensor technology
Clinical chemistry
Others
End Use (Revenue, USD Million; 2016–2026)
Hospital
Commercial Laboratory
Ambulatory Care Centres
Others
Ask For Discount: https://www.reportsanddata.com/discount-enquiry-form/2240
Regional Outlook (Revenue in USD Million; 2016–2026)
North America
US.
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of the Europe
Asia Pacific
China
India
Japan
Rest of Asia-Pacific
Middle East & Africa
Latin America
Brazil
Request For Customization: https://www.reportsanddata.com/request-customization-form/2240
Thank you for taking out time to read our report. We also offer report customization according to client’s requirement. Kindly connect with us to know more about customization plan and our team will offer you the report as per the modifications.
About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com/
Direct Line: +1-212-710-1370
E-mail: [email protected]
A novel research report on Global Endocrine Testing Systems Market has been recently published by Reports and Data covering latest trends and key market developments during the forecast period from 2018 to 2026.
The report offers an in-depth analysis of forecast insights, market size, emerging trends, revenue growth, top companies, growth factors, restraints and opportunities in the global Endocrine Testing Systems market.
The report also offers an accurate analysis of competitive landscape, sales statistics and regional manufactures.
The data has been extracted through extensive research and is further validated by professionals and experts in the industry.
The report uses charts, graphs, tables and figures to visually reflect the statistical data collected and makes it easier for readers to understand the market situation.
The report also provides insights of the top key companies operating the market.Request Free Sample: https://www.reportsanddata.com/sample-enquiry-form/2240 Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness, increasing government support & obesity are some of the key factors projected to surge the demand for Endocrine testing, thereby propelling the market growth.
Get FREE Sample Report Before Buying @ https://www.upmarketresearch.com/home/requested_sample/3340 UpMarketResearch offers a latest published report on “Global Endocrine Testing System Market Analysis and Forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Region-wise Analysis Global Endocrine Testing System Market covers:North AmericaEuropeChinaJapanIndiaSoutheast AsiaOther regions (Central & South America, Middle East & Africa) The Major players reported in the market include:Abbott DiagnosticsDiascorinRoche DiagnosticsSiemens HealthcareThermo Fisher ScientificAdnaGenImmunoDXImmunonodiagnostics SystemInDevRInnogeneticsKyowa Medex For More Information, Please Visit https://www.upmarketresearch.com/home/enquiry_before_buying/3340 Global Endocrine Testing System Market: Product Segment Analysis:Estradiol (E2) TestFollicle Stimulating Hormone (FSH) TestHuman Chorionic Gonadotropin (HCG) Hormone TestLuteinizing Hormone (LH) TestDehydroepiandrosterone Sulfate (DHEAS) TestProgesterone Test Global Endocrine Testing System Market: Application Segment Analysis:HospitalsCommercial LaboratoriesAmbulatory Care CentersHome-based tests The Report covers in-depth analysis as follows:Chapter 1 Overview of Endocrine Testing SystemChapter 2 Global Market Status and Forecast by RegionsChapter 3 Global Market Status and Forecast by TypesChapter 4 Global Market Status and Forecast by Downstream IndustryChapter 5 Market Driving Factor Analysis of Endocrine Testing SystemChapter 6 Endocrine Testing System Market Competition Status by Major ManufacturersChapter 7 Endocrine Testing System Major Manufacturers Introduction and Market DataChapter 8 Upstream and Downstream Market Analysis of Endocrine Testing SystemChapter 9 Cost and Gross Margin Analysis of Endocrine Testing SystemChapter 10 Marketing Status Analysis of Endocrine Testing SystemChapter 11 Report ConclusionChapter 12 Research Methodology and Reference Buy Endocrine Testing System Market analysis & forecast 2018-2023 Report along with complete TOC @ https://www.upmarketresearch.com/buy/Endocrine-Testing-System-Global-Market-Status-and-Trend-Report-2013-2023 “Endocrine Testing System Market Analysis and Forecast 2018-2023” report helps the clients to take business decisions and to understand strategies of major players in the industry.
Transparency Market Research (TMR) () has published a new report titled, ‘Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global endocrine testing market was valued at US$ 5.5 Bn in 2018 and is projected to expand at a CAGR of 6.4% from 2019 to 2027.Read Report Overview - https://www.transparencymarketresearch.com/endocrine-testing-market.html OverviewEndocrine system is made up of endocrine glands that secrete hormones directly into the blood stream.
they help detect either hypersecretion (excess secretion) or hyposecretion (less secretion) that results in certain endocrine disorders such as infertility, menopause, thyroid dysfunction and others.The Endocrine Testing market is currently booming one, owing to consistent rise in diabetic and obese population resulting in development of several health disorders thereby enhancing the growth and acceptance of endocrine test kits and methodologies.
Moreover endocrine test kit manufacturers are focusing on the development of efficient diagnostic test kits of high accuracy which are the factors anticipated to drive the growth of market.North America dominates the global endocrine testing market in 2018 and the trend is anticipated to continue during the forecast period.
The growth of market in the region is attributed to increasing obesity and changing lifestyle and less physical inactivity resulting in several endocrine disorders., Also, increasing incidences of diabetes worldwide followed by constant technological upgradation in testing further propel the growth and adoption of endocrine testing platforms.Asia Pacific is likely to be a highly lucrative market for the Endocrine Testing market and it is expected to expand at a high CAGR during the forecast period.
Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost endocrine testing market in Asia Pacific.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1645Rise in Prevalence of Endocrine and Metabolic Disorders to Drive Global Endocrine Testing MarketDisorders such as hypothyroidism, hyperthyroidism, diabetes mellitus, polycystic ovary syndrome (PCOS) among others are the most common endocrine & metabolic disorders among the global population.
Global Endocrine Testing Market is expected to reach USD 13.02 billion by 2024.
With the help of network of glands, hormones are produced, stored, and secreted.
Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the pancreas, thyroid, and parathyroid are glands of endocrine system.
Insulin, estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the forecast period.
Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing industry and is estimated to lead the overall market in the coming years.
Moreover, insulin test is estimated to grow at fastest pace in the coming years, as growing diabetic population.
